Howell App Flashcards
risk factors of prostate cancer
Age
Race
Family History
High fat diet
shared decision making
working with patient to determine outcome
PSA, DRE
PSA
glycoprotein produced only by prostate
prostate specific antigen
tumor marker - increases in levels due to increase in size of prostate
Screening PSA
(sensitive/specific) + when to start
SENSITIVE not specific (bc it doesn’t eliminate other possible causes)
Begin checking PSA at 40, or 10 years prior to first degree relative diagnosis
PSA Velocity
used as a screening risk
check PSA range over time
Rise of >0.35 ng/mL indicates “rapid” increase
reasons why PSA could be elevated (5)
malignancy UTI prostatitis prostatic trauma BPH
abnormal findings on DRE
induration or nodularity
prostate should be considered suspicious for prostate cancer
limitations of DRE
Finger length
body habitus of patient
Prostate Cancer metastasis
bone meds to lower back
evaluate with bone scan + Xray
Histologic type of prostate cancer
Adenocarcinoma
Diagnostic analysis of prostate cancer
- Prostate biopsy via TRUS
- MRI
- Conventional radionucletide bone scan
Prostate Biopsy via Transrectal Ultrasound
Tumors are hypoechoic on TRUS
TRUS IS NOT first line alone
Expensive, invasive, LOW specificity
Standard method of detecting/proving prostate CA
Prostate biopsy via TRUS
MRI prostate cancer benefits
Evaluation of prostate as well as regional lymph nodes
Better at staging than TRUS
Non-invasive, non-radiation
scale used in staging of prostate cancers
Gleason scale
stage 1
No symptoms, confined to prostate
stage 2
Hard nodule on rectal exam, confined within prostate
stage 3
Spread out of prostate capsule, urinary symptoms appear